News

AptarGroup, Inc., a global leader in dispensing, drug delivery and active packaging solutions, announced that it has partnered with PureCycle Technologies, to prepare for the introduction of PureCycle’s Ultra-Pure Recycled Polypropylene (UPRP) into dispensing applications. PureCycle’s ground-breaking, patented recycling process,...

Thermo Fisher Scientific and Cedars-Sinai, a non-profit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography-mass spectrometry (LC-MS)-based workflows for clinical research applications. Bringing...

As predicted by the ‘European drug delivery and packaging’ report earlier this year, new data shows innovation in drug delivery is accelerating across Europe – with provisional findings from the Pharmapack Innovation Index (2020) showing that Switzerland has over...

Aurora Capital Partners , a leading middle-market private equity firm, announced the acquisition of Cold Chain Technologies , a leading global provider of single-use and reusable passive thermal packaging solutions that ensure reliable shipment of temperature-sensitive materials, principally serving...

CSafe Global, the innovation leader in active temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, is pleased to announce the opening of a new service center in The Netherlands. This expanded facility will enable CSafe to further enhance...

Royal Cargo has announced that its Pharma/Clinical Trial Logistics and Premium Courier Service unit passed the Good Distribution Practices (GDP) re-certification audit. Pharma Logistics is a business unit of this Philippines-based company that provides Logistics Management Solutions for Pharmaceutical and...

Cancer Research UK, the world’s leading cancer charity, and Hummingbird Bioscience, an innovative systems-biology enabled biotechnology company, have announced a partnership to develop Hummingbird’s anti-HER3 antibody drug, HMBD-001, for the treatment of people with HER3 driven cancer. Under the terms...